Philip Rosenthal, M.D.

Pediatric liver specialist

Dr. Philip Rosenthal, a hepatologist or liver specialist at UCSF Benioff Children's Hospital, is internationally renowned for the care of children with liver disease, including liver cancer, and the care of patients who undergo liver transplants. Rosenthal, director of Pediatric Hepatology, treats children and young adults up to age 21.

Rosenthal has won many honors for his research including work on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary atresia and the quality of life after liver transplants in children. He is a consultant to organizations such as the American Liver Foundation, Parents of Kids with Infectious Diseases, Alagille Syndrome Alliance, Studies of Pediatric Liver Transplantation (SPLIT), Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). He joined UCSF Benioff Children's Hospital in 1995 from the UCLA Medical Center. Rosenthal is a professor of pediatrics and surgery at UCSF.

Clinics

Gastroenterology and Liver
400 Parnassus Ave., Second Floor
San Francisco, CA 94143
Phone: (415) 353-2813

Intestinal Rehabilitation and Transplantation Program
400 Parnassus Ave., 2nd Floor
San Francisco, CA 94143
Phone: (877) 762-6935

Liver Transplant Program
400 Parnassus Ave., Sixth Floor
San Francisco, CA 94143
Phone: (415) 476-5892

Conditions & Treatments

More about Philip Rosenthal

Education

SUNY Brooklyn School of Medicine 1975

Residencies

Albert Einstein Medical Center, Pediatrics 1978

Fellowships

UCSF Medical Center, Gastroenterology 1981

Selected Research and Publications

  1. Venkat VL, Shneider BL, Magee JC, Turmelle Y, Arnon R, Bezerra JA, Hertel PM, Karpen SJ, Kerkar N, Loomes KM, Molleston J, Murray KF, Ng VL, Raghunathan T, Rosenthal P, Schwartz K, Sherker AH, Sokol RJ, Teckman J, Wang K, Whitington PF, Heubi JE. Total serum bilirubin predicts fat-soluble vitamin deficiency better than serum bile acids in infants with biliary atresia. J Pediatr Gastroenterol Nutr. 2014 Dec; 59(6):702-7.
  2. Perito ER, Rosenthal P. Delineating definitions and risk factors for metabolic syndrome after pediatric liver transplantation. Liver Transpl. 2014 Oct; 20(10):1280.
  3. Bigira V, Kapisi J, Clark TD, Kinara S, Mwangwa F, Muhindo MK, Osterbauer B, Aweeka FT, Huang L, Achan J, Havlir DV, Rosenthal PJ, Kamya MR, Dorsey G. Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young ugandan children: a randomized controlled trial. PLoS Med. 2014 Aug; 11(8):e1001689.
  4. Ng VL, Haber BH, Magee JC, Miethke A, Murray KF, Michail S, Karpen SJ, Kerkar N, Molleston JP, Romero R, Rosenthal P, Schwarz KB, Shneider BL, Turmelle YP, Alonso EM, Sherker AH, Sokol RJ. Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a north american multicenter consortium. J Pediatr. 2014 Sep; 165(3):539-546.e2.
  5. Wanzira H, Kakuru A, Arinaitwe E, Bigira V, Muhindo MK, Conrad M, Rosenthal PJ, Kamya MR, Tappero JW, Dorsey G. Longitudinal outcomes in a cohort of ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria. Clin Infect Dis. 2014 Aug 15; 59(4):509-16.
  6. Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS, Erlichman J, Haber B, Hertel PM, Karpen SJ, Kerkar N, Loomes KM, Molleston JP, Murray KF, Romero R, Schwarz KB, Shepherd R, Suchy FJ, Turmelle YP, Whitington PF, Moore J, Sherker AH, Robuck PR, Sokol RJ. Use of Corticosteroids After Hepatoportoenterostomy for Bile Drainage in Infants With Biliary Atresia: The START Randomized Clinical Trial. JAMA. 2014 May 7; 311(17):1750-9.
  7. Mbogo GW, Nankoberanyi S, Tukwasibwe S, Baliraine FN, Nsobya SL, Conrad MD, Arinaitwe E, Kamya M, Tappero J, Staedke SG, Dorsey G, Greenhouse B, Rosenthal PJ. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda. Am J Trop Med Hyg. 2014 Jul 2; 91(1):54-61.
  8. Hsiang MS, Greenhouse B, Rosenthal PJ. Point of Care Testing for Malaria Using LAMP, Loop Mediated Isothermal Amplification. J Infect Dis. 2014 Oct 15; 210(8):1167-9.
  9. Kakuru A, Achan J, Muhindo MK, Ikilezi G, Arinaitwe E, Mwangwa F, Ruel T, Clark TD, Charlebois E, Rosenthal PJ, Havlir D, Kamya MR, Tappero JW, Dorsey G. Artemisinin-Based Combination Therapies Are Efficacious and Safe for Treatment of Uncomplicated Malaria in HIV-Infected Ugandan Children. Clin Infect Dis. 2014 Aug 1; 59(3):446-53.
  10. Rosenthal P. Another explanation for breast milk jaundice. J Pediatr. 2014 Jul; 165(1):10-1.
  11. Ruel TD, Kakuru A, Ikilezi G, Mwangwa F, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Kamya M, Achan J. Virologic and Immunologic Outcomes of HIV-Infected Ugandan Children Randomized to Lopinavir/Ritonavir or Nonnucleoside Reverse Transcriptase Inhibitor Therapy. J Acquir Immune Defic Syndr. 2014 Apr 15; 65(5):535-41.
  12. Nankabirwa JI, Wandera B, Amuge P, Kiwanuka N, Dorsey G, Rosenthal PJ, Brooker SJ, Staedke SG, Kamya MR. Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in ugandan schoolchildren: a randomized, placebo-controlled trial. Clin Infect Dis. 2014 May; 58(10):1404-12.
  13. Gaynor BD, Amza A, Kadri B, Nassirou B, Lawan O, Maman L, Stoller NE, Yu SN, Chin SA, West SK, Bailey RL, Rosenthal PJ, Keenan JD, Porco TC, Lietman TM. Impact of Mass Azithromycin Distribution on Malaria Parasitemia during the Low-Transmission Season in Niger: A Cluster-Randomized Trial. Am J Trop Med Hyg. 2014 May; 90(5):846-51.
  14. Perito ER, Rhee S, Roberts JP, Rosenthal P. Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012. Liver Transpl. 2014 Jan; 20(1):89-99.
  15. Mohan P, Barton BA, Narkewicz MR, Molleston JP, Gonzalez-Peralta RP, Rosenthal P, Murray KF, Haber B, Schwarz KB, Goodman ZD. Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: A retrospective study. Hepatology. 2013 Nov; 58(5):1580-6.
  16. Schwarz KB, Haber BH, Rosenthal P, Mack CL, Moore J, Bove K, Bezerra JA, Karpen SJ, Kerkar N, Shneider BL, Turmelle YP, Whitington PF, Molleston JP, Murray KF, Ng VL, Romero R, Wang KS, Sokol RJ, Magee JC. Extrahepatic anomalies in infants with biliary atresia: results of a large prospective north american multicenter study. Hepatology. 2013 Nov; 58(5):1724-31.
  17. Gong L, Parikh S, Rosenthal PJ, Greenhouse B. Biochemical and immunological mechanisms by which sickle cell trait protects against malaria. Malar J. 2013; 12(1):317.
  18. Rosenthal PJ. The interplay between drug resistance and fitness in malaria parasites. Mol Microbiol. 2013 Sep; 89(6):1025-38.
  19. Publicover J, Gaggar A, Nishimura S, Van Horn CM, Goodsell A, Muench MO, Reinhardt RL, van Rooijen N, Wakil AE, Peters M, Cyster JG, Erle DJ, Rosenthal P, Cooper S, Baron JL. Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest. 2013 Sep 3; 123(9):3728-39.
  20. Sundaram SS, Alonso EM, Haber B, Magee JC, Fredericks E, Kamath B, Kerkar N, Rosenthal P, Shepherd R, Limbers C, Varni JW, Robuck P, Sokol RJ. Health related quality of life in patients with biliary atresia surviving with their native liver. J Pediatr. 2013 Oct; 163(4):1052-7.e2.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.